Home › Funds › Burkehill Global Management, LP › TRVI

Burkehill Global Management, LP position in TRVI

TREVI THERAPEUTICS INC · Health Care

Burkehill Global Management, LP reported holding 725,000 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.4M, representing 0.45% of its reported portfolio and ranking #33 among its reported holdings. Burkehill Global Management, LP has disclosed TRVI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)725.00K sh
Reported value held$10.38M
Portfolio Weight0.45%
First reportedQ2 2025
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Burkehill Global Management, LP's TRVI position evolved

Burkehill Global Management, LP first disclosed a stake in TRVI in Q2 2025 at 525,000 shares (US$2.9M). The position peaked in Q2 2026 at 725,000 shares, worth US$13.5M. Across 6 filings, Burkehill Global Management, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 725,000 shares valued at US$10.4M. Notable position changes include a 38% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 525.00K $2.87M New
Q3 2025 525.00K $4.80M Hold
Q4 2025 525.00K $6.57M Hold
Q1 2026 525.00K $6.26M Hold
Q2 2026 725.00K $13.52M Add
Q3 2026 725.00K $10.38M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$189.3M), Frazier Life Sciences Management, L.P. (US$136.6M), Vivo Capital, LLC (US$60.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has Burkehill Global Management, LP held TRVI?

Burkehill Global Management, LP has disclosed TRVI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Burkehill Global Management, LP's current position in TRVI?

As of Q3 2026, Burkehill Global Management, LP holds 725.00K shares of TRVI (TREVI THERAPEUTICS INC), valued at $10.38M, representing 0.45% of its reported portfolio and ranking #33.

Has Burkehill Global Management, LP been buying or selling TRVI?

In the latest 13F filing (Q3 2026), Burkehill Global Management, LP held unchanged its position in TRVI. The position peaked in Q2 2026 at 725.00K shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.